2020 |
Abrahamsen B, Laursen HVB, Skjødt MK, Jensen MH, Vestergaard P. Age at hip fracture and life expectancy in Denmark: secular trends over two decades. Bone. January 2020;130:115083. |
1 |
1 |
2020 |
Rubin KH, Möller S, Choudhury A, Zorina O, Kalsekar S, Eriksen EF, Andersen M, Abrahamsen B. Cardiovascular and skeletal safety of zoledronic acid in osteoporosis observational, matched cohort study using Danish and Swedish health registries. Bone. May 2020;134:115296. |
3 |
3 |
2020 |
Abrahamsen B, Ernst MT, Smith CD, Nybo M, Rubin KH, Prieto-Alhambra D, Hermann AP. The association between renal function and BMD response to bisphosphonate treatment: real-world cohort study using linked national registers. Bone. August 2020;137:115371. |
0 |
0 |
2021 |
Skjødt MK, Möller S, Hyldig N, Clausen A, Bliddal M, Søndergaard J, Abrahamsen B, Rubin KH. Validation of the fracture risk evaluation model (FREM) in predicting major osteoporotic fractures and hip fractures using administrative health data. Bone. June 2021;147:115934. |
1 |
1 |
2022 |
Lykking EK, Kammerlander H, van Dijk FS, Prieto-Alhambra D, Abrahamsen B, Folkestad L. Fractures following pregnancy in osteogenesis imperfecta: a self-controlled case series using Danish Health Registers. Bone. January 2022;154:116177. |
0 |
0 |
2022 |
Andersen JD, Folkestad L, Hald JD, Harsløf T, Langdahl BL, Abrahamsen B. Osteoarthritis in osteogenesis imperfecta: a nationwide register-based cohort study. Bone. January 2022;154:116222. |
1 |
1 |
2022 |
Mattia L, Davis S, Mark-Wagstaff C, Abrahamsen B, Peel N, Eastell R, Schini M. Utility of PINP to monitor osteoporosis treatment in primary care, the POSE study (PINP and Osteoporosis in Sheffield Evaluation). Bone. May 2022;158:116347. |
1 |
1 |
2023 |
Skjødt MK, Nicolaes J, Smith CD, Libanati C, Cooper C, Olsen KR, Abrahamsen B. Healthcare costs associated with opportunistically identifiable vertebral fractures. Bone. October 2023;175:116831. |
0 |
0 |
2020 |
Sami A, Abrahamsen B. The latest evidence from vitamin d intervention trials for skeletal and non-skeletal outcomes. Calcif Tiss Int. January 2020;106(1):88-93. |
1 |
1 |
2010 |
Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MCH, Weinstein RS, Whyte M. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. November 2010;25(11):2267-2294. |
62 |
45 |
2014 |
Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MCH, Weinstein RS, Whyte MP. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. January 2014;29(1):1-23. |
58 |
42 |
2020 |
Alarkawi D, Ali MS, Bliuc D, Pallares N, Tebe C, Elhussein L, Caskey FJ, Arden NK, Ben‐Shlomo Y, Abrahamsen B, Diez‐Perez A, Pascual J, Pérez‐Sáez MJ, Center JR, Judge A, Cooper C, Javaid MK, Prieto‐Alhambra D. Oral bisphosphonate use and all‐cause mortality in patients with moderate–severe (grade 3B‐5D) chronic kidney disease: a population‐based cohort study. J Bone Miner Res. May 2020;35(5):894-900. |
1 |
1 |
2021 |
Seeto AH, Abrahamsen B, Ebeling PR, Rodríguez AJ. Cardiovascular safety of denosumab across multiple indications: a systematic review and meta‐analysis of randomized trials. J Bone Miner Res. January 2021;36(1):24-40. |
1 |
0 |
2021 |
Seeto AH, Abrahamsen B, Ebeling PR, Rodríguez AJ. Response to Shao et al. J Bone Miner Res. March 2021;36(3):619-620. |
0 |
0 |
2021 |
Robinson DE, Ali MS, Pallares N, Tebé C, Elhussein L, Abrahamsen B, Arden NK, Ben-Shlomo Y, Caskey FJ, Cooper C, Dedman D, Delmestri A, Judge A, Pérez-Sáez MJ, Pascual J, Nogues X, Diez-Perez A, Strauss VY, Javaid MK, Prieto-Alhambra D. Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis. J Bone Miner Res. May 2021;36(5):820-832. |
3 |
2 |
2022 |
Vilaca T, Velmurugan N, Smith C, Abrahamsen B, Eastell R. Osteomalacia as a complication of intravenous iron infusion: a systematic review of case reports. J Bone Miner Res. June 2022;37(6):1188-1199. |
0 |
0 |
2023 |
Nicolaes J, Skjødt MK, Raeymaeckers S, Smith CD, Abrahamsen B, Fuerst T, Debois M, Vandermeulen D, Libanati C. Towards improved identification of vertebral fractures in routine computed tomography (CT) scans: development and external validation of a machine learning algorithm. J Bone Miner Res. December 2023;38(12):1856-1866. |
0 |
0 |
2017 |
Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL; IOF Bone and Diabetes Working Group. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. April 2017;13(4):208-219. |
37 |
33 |
2009 |
Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. October 2009;20(10):1633-1650. |
37 |
36 |
2020 |
Hoff M, Skovlund E, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U, Forsmo S, Abrahamsen B, Schei B. Proton pump inhibitors and fracture risk: the HUNT study, Norway. Osteoporos Int. January 2020;31(1):109-118. |
0 |
0 |
2020 |
Skjødt MK, Khalid S, Ernst M, Rubin KH, Martinez-Laguna D, Delmestri A, Javaid MK, Cooper C, Libanati C, Toth E, Abrahamsen B, Prieto-Alhambra D. Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom. Osteoporos Int. August 2020;31(8):1535-1544. |
2 |
0 |